Pennsylvania Prisons Spend $36M on Suboxone MAT Programs

Pennsylvania is spending $36.7 million a year on Suboxone-based medication-assisted treatment inside its state prisons, and the price tag is still climbing.

The program now covers more than 5,000 inmates with opioid use disorder, with thousands more waiting to be screened. As corrections systems nationwide bet big on MAT, the debate over its costs, effectiveness, and long-term outcomes is intensifying.

What the $36M Suboxone Spend Tells Us About MAT

Pennsylvania’s inmate population on Suboxone has surged 184% in just two years, jumping from 1,800 to more than 5,000, with an additional 4,000 on a waiting list.

The price varies sharply by formulation: a monthly injectable form of buprenorphine costs $1,630 per dose, while oral medication runs about $55 a month. Those figures don’t include spending at county jails like the Allegheny County Jail.

Supporters point to strong evidence: addiction specialist David Loveland cites reduced overdose risk, greater likelihood of entering recovery, and fewer hospitalizations as justification for the cost. Opponents argue the state is subsidizing long-term dependency rather than fostering genuine recovery.

What Is Suboxone and How Does It Work in Detox

Suboxone is a combination of buprenorphine and naloxone, two medications with distinct roles in opioid detox. Buprenorphine is a partial opioid agonist, it activates opioid receptors enough to suppress withdrawal symptoms and cravings without producing the full high of drugs like heroin or fentanyl.

Naloxone is an opioid antagonist added to deter misuse: if the medication is injected rather than taken sublingually as prescribed, naloxone triggers immediate withdrawal.

Together, they form a frontline FDA-approved medication-assisted treatment endorsed by SAMHSA and the American Society of Addiction Medicine. MAT with buprenorphine is typically initiated during medically supervised detox and continued through longer-term treatment.

Why Medical Detox Matters for Opioid Use Disorder

The $36 million question in Pennsylvania reflects a nationwide reckoning with what evidence-based opioid detox actually requires.

For people dependent on opioids, quitting without medical supervision is dangerous, not only because withdrawal is severe, but because tolerance drops rapidly during abstinence, dramatically raising overdose risk if relapse occurs.

Medical detox stabilizes patients through acute withdrawal, manages symptoms with medication, and creates a bridge into ongoing MAT or residential treatment. Done properly, it’s not just about getting through the first 72 hours, it’s the foundation for durable recovery.

It’s also worth noting what opioid detox is not. Unlike alcohol or benzodiazepine withdrawal, which can cause life-threatening seizures, opioid withdrawal is rarely fatal on its own. But the medical risks of relapse post-detox make supervision critical regardless.

Anyone dependent on alcohol or benzodiazepines must never attempt detox without medical supervision. Seizures can occur within hours of the last drink or dose.

Is the MAT Investment Worth It

Pennsylvania Department of Corrections Secretary Laurel Harry notes that roughly 57% of the state’s prison population has a substance use history, a figure that underscores why corrections systems are turning to MAT at scale.

The argument for spending is straightforward: if medication-assisted treatment reduces recidivism and keeps formerly incarcerated people out of the criminal justice system, the long-term savings to the state may outweigh the upfront cost.

Critics like recovery house operator Jim Antal counter that expanding Suboxone use simply creates a population dependent on a different substance, without addressing the underlying disorder.

That tension, between harm reduction and abstinence-based recovery, is not unique to prisons. It plays out daily in detox centers, outpatient clinics, and recovery communities across Pennsylvania and the country.

Finding Medication-Assisted Treatment in Pennsylvania

If you or someone you love is dependent on opioids, medically supervised detox programs offering Suboxone and other MAT options are available across Pennsylvania, in Pittsburgh, Philadelphia, and communities statewide.

Call 800-996-6135(Sponsored) to speak with a treatment specialist about medical detox centers in Pennsylvania that provide evidence-based medication-assisted treatment.